We primarily invest in start-ups in highly attractive markets with above-average growth rates in the areas of Nutrition & Care, Specialty Additives and Smart Materials. A particular focus of our investment activities are the Evonik Innovation Growth Fields as well as enabling digital technologies.
Innovation Growth Fields
Development and expansion of ready-to use materials and production technologies for additive manufacturing. Areas of focus include binder jetting and powder bed infusion.
Building a portfolio of ingredients with documented health benefits combined with delivery technologies to improve bioavailability and a limited range of B2C products for consumer insights.
Generating novel competencies and technologies for cosmetic skin care applications by organic innovation and external growth in the areas of active ingredients, biotechnology, smart formulations and digitization.
Building a portfolio of enabling healthcare technologies, services, and product solutions to serve our pharmaceutical and medical device partners with a focus on functional excipients, specialty drug delivery, API manufacture, cell & tissue, and medical technologies.
Development of new polymer-based membranes and expansion of product portfolio for efficient separation technologies in new application areas such as natural gas, process gas or renewable hydrogen.
New products and solutions for efficient, healthy and sustainable animal nutrition that will ultimately meet the needs for high quality meat and seafood of a growing world population. Focus areas in this growth field include precision livestock farming and sustainable aquaculture solutions.